BioNTech/Pfizer expect new variant impact data 'within 2 weeks'

FRANKFURT: Germany’s BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.

© New Straits Times Press (M) Bhd